Indian Journal of Urology
REVIEW ARTICLE
Year
: 2022  |  Volume : 38  |  Issue : 1  |  Page : 7--14

Focal therapy for localized prostate cancer – Current status


Shrikanth Atluri, Ali Mouzannar, Vivek Venkatramani, Dipen J Parekh, Bruno Nahar 
 Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA

Correspondence Address:
Bruno Nahar
Department of Urology, University of Miami Miller School of Medicine, Miami, FL
USA

Focal therapy (FT) has recently gained popularity for the treatment of localized prostate cancer (PCa). FT achieves cancer control by targeting the lesions or the regions of the cancer and avoids damage to the surrounding tissues thus minimizing side effects which are common to the radical treatment, such as urinary continence and sexual function, and bowel-related side effects. Various ablative methods are used to deliver energy to the cancerous tissue. We review the different modalities of treatment and the current state of FT for PCa.


How to cite this article:
Atluri S, Mouzannar A, Venkatramani V, Parekh DJ, Nahar B. Focal therapy for localized prostate cancer – Current status.Indian J Urol 2022;38:7-14


How to cite this URL:
Atluri S, Mouzannar A, Venkatramani V, Parekh DJ, Nahar B. Focal therapy for localized prostate cancer – Current status. Indian J Urol [serial online] 2022 [cited 2022 Jan 28 ];38:7-14
Available from: https://www.indianjurol.com/article.asp?issn=0970-1591;year=2022;volume=38;issue=1;spage=7;epage=14;aulast=Atluri;type=0